日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Optimizing energy consumption in radiotherapy: standard vs. hypo-/ultra-hypofractionation and becoming SMART (specific, measurable, achievable in radiotherapy)

优化放射治疗中的能量消耗：标准分割与低/超低分割，并实现SMART（放射治疗中具体、可测量、可实现）

期刊:Strahlentherapie Und Onkologie
影响因子:2.5
doi:10.1007/s00066-025-02419-7
Exeli, Ann-Katrin; Lurtz, Andreas; Agolli, Linda; Habermehl, Daniel
发表日期：2026
文献求助 收藏

Sex-based differences in patients with locally advanced pharyngeal and laryngeal SCC treated with definitive or adjuvant radiotherapy

接受根治性或辅助性放疗的局部晚期咽喉鳞状细胞癌患者的性别差异

期刊:Radiation Oncology
影响因子:3.2
doi:10.1186/s13014-025-02771-z
Agolli, Linda; Reinhard, Luise; Gawish, Ahmed; Langer, Christine; Arens, Christoph; Krombach, Gabriele A; Harth, Sebastian; Wendrich, Leon; Exeli, Ann-Katrin; Gattenlöhner, Stefan; Adeberg, Sebastian; Habermehl, Daniel
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Development of heart-sparing VMAT radiotherapy technique incorporating heart substructures for advanced NSCLC patients

针对晚期非小细胞肺癌患者，开发包含心脏亚结构的心脏保护性容积旋转调强放射治疗（VMAT）技术

期刊:Radiation Oncology
影响因子:3.2
doi:10.1186/s13014-025-02597-9
Agolli, Linda; Exeli, Ann-Katrin; Schneider, Uwe; Ihne-Schubert, Sandra Michaela; Lurtz, Andreas; Habermehl, Daniel
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Defining failure patterns and dynamics in locally advanced pharyngeal and laryngeal SCC following radiotherapy: Real-World Insights in the modern Era!

定义局部晚期咽喉鳞状细胞癌放射治疗后的失败模式和动态：现代的真实世界见解！

期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2025.101026
Agolli, Linda; Reinhard, Luise; Langer, Christine; Arens, Christoph; Krombach, Gabriele A; Harth, Sebastian; Lurtz, Andreas; Exeli, Ann-Katrin; Gattenlöhner, Stefan; Habermehl, Daniel
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Very pronounced bowel sparing during radiation therapy for anal carcinoma using a natural spacer (Myoma) - a case report

利用天然间隔物（肌瘤）进行肛门癌放射治疗期间肠道保护效果显著——病例报告

期刊:Radiation Oncology
影响因子:3.2
doi:10.1186/s13014-024-02530-6
Hoeng, L; Exeli, A K; Krombach, G A; Schwandner, T; Agolli, L; Habermehl, D
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Outcome of whole brain irradiation with a dose-escalated simultaneous-integrated boost in patients with multiple large and/or diffuse brain metastases: real live data and review of the literature

全脑照射联合剂量递增同步整合照射治疗多发性大面积和/或弥漫性脑转移瘤患者的疗效：真实数据及文献综述

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-024-01176-w
Agolli, Linda; Nicosia, Luca; Hilger, Thomas; Iancu, Gheorghe; Exeli, Ann-Katrin; Eul, Bastian; Struffert, Tobias; Acker, Till; Habermehl, Daniel
神经科学
发表日期：2024
文献求助 收藏

Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning

胶质母细胞瘤患者大脑皮层剂量保护：调强放射治疗与稳健治疗计划的比较

期刊:Radiation Oncology
影响因子:3.2
doi:10.1186/s13014-018-0953-x
Exeli, Ann-Katrin; Kellner, Daniel; Exeli, Lukas; Steininger, Phil; Wolf, Frank; Sedlmayer, Felix; Deutschmann, Heinz
细胞生物学
神经科学
发表日期：2018
文献求助 收藏

DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints

DART-bid 用于局部晚期非小细胞肺癌：长期随访的急性和远期毒性总结；肺部剂量限制经验

期刊:Strahlentherapie Und Onkologie
影响因子:2.5
doi:10.1007/s00066-016-1095-4
Wurstbauer, Karl; Zehentmayr, Franz; Deutschmann, Heinz; Dagn, Karin; Exeli, Ann-Katrin; Kopp, Peter; Porsch, Peter; Maurer, Birgit; Studnicka, Michael; Sedlmayer, Felix
肺癌
肿瘤
肿瘤免疫
细胞生物学
毒理研究
发表日期：2017
文献求助 收藏

Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)

接受剂量差异加速放射治疗（DART-bid）的患者中，临床相关急性食管炎（≥ 2 级）的正常组织并发症模型

期刊:Radiation Oncology
影响因子:3.2
doi:10.1186/s13014-015-0429-1
Zehentmayr, Franz; Söhn, Matthias; Exeli, Ann-Katrin; Wurstbauer, Karl; Tröller, Almut; Deutschmann, Heinz; Fastner, Gerd; Fussl, Christoph; Steininger, Philipp; Kranzinger, Manfred; Belka, Claus; Studnicka, Michael; Sedlmayer, Felix
发表日期：2015
文献求助 收藏